0 items USD 0.00Search
- Did you mean
- current partners biogen idex partners 2029 2024
Your search for "current partnering biogen idec partnering 2009 2014" gave back 202 results.
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,514.00
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field...
Catalog:
La Merie Publishing
April 2015
Price: USD 1,500.00
CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors The present Competitive Intelligence Report about CD20 Antibodies - Rituximab...
Catalog:
La Merie Publishing
February 2014
Price: USD 401.00
This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the...
Catalog:
La Merie Publishing
March 2015
Price: USD 346.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective This...
Catalog:
La Merie Publishing
September 2019
Price: USD 2,350.00
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding: ADC pipeline, ADC technologies, ADC...
Catalog:
La Merie Publishing
November 2015
Price: USD 2,500.00
Biotechnology in the United States Summary Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary...
Catalog:
MarketLine
December 2019
Price: USD 350.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Chronic Lymphocytic Leukemia Drugs market will undergo...
Catalog:
Arsta
January 2023
Price: USD 3,490.00
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but „difficult-to-drug“ target. More than 30 companies are active in drug...
Catalog:
La Merie Publishing
February 2016
Price: USD 1,050.00
Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and...
Catalog:
WinterGreen Research
October 2017
Price: USD 4,200.00
Important bispecific antibody targets are basically in clinical practice, and many momentous bispecific antibodies will be born in the future. The...
Catalog:
AEI
June 2021
Price: USD 3,000.00
The report “Antibody Technologies and Attrition Rates – an industry analysis 2013” is based on the identification of the antibody generation...
Catalog:
La Merie Publishing
March 2013
Price: USD 2,960.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Ambulatory Surgery Center Services market will undergo...
Catalog:
Arsta
April 2023
Price: USD 3,600.00
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
Catalog:
La Merie Publishing
June 2019
Price: USD 2,700.00
